{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:05:42Z","timestamp":1771063542691,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Applied Radiation and Isotopes"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.apradiso.2024.111300","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T22:10:02Z","timestamp":1711318202000},"page":"111300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Evaluation of 188Re- IBA as a novel radiopharmaceutical for bone marrow ablation"],"prefix":"10.1016","volume":"208","author":[{"given":"Hassan","family":"Ranjbar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed-Milad","family":"Miremad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.apradiso.2024.111300_bib1","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.3390\/cancers13164229","article-title":"Recent advances in the treatment of bone metastases and primary bone tumors: an up-to-date review","volume":"13","author":"B\u0103dil\u0103","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.apradiso.2024.111300_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.radphyschem.2021.109560","article-title":"Estimation of radiation absorbed dose in man from 166Ho-EDTMP based on biodistribution data in Wistar rats","volume":"187","author":"Bagheri","year":"2021","journal-title":"Radiat. Phys. Chem."},{"key":"10.1016\/j.apradiso.2024.111300_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2022.110250","article-title":"Dose evaluation of auger electrons emitted from the 119Sb in cancer treatment","volume":"185","author":"Bastami","year":"2022","journal-title":"Appl. Radiat. Isot."},{"issue":"2","key":"10.1016\/j.apradiso.2024.111300_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10967-021-08183-z","article-title":"Preparation and validation of [67Ga] Ga-phytate kit and Monte Carlo dosimetry: an effort toward developing an impressive lymphoscintigraphy tracer","volume":"331","author":"Bayat","year":"2022","journal-title":"J. Radioanal. Nucl. Chem."},{"issue":"3","key":"10.1016\/j.apradiso.2024.111300_bib6","first-page":"534","article-title":"166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy","volume":"47","author":"Breitz","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2024.111300_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2022.110113","article-title":"Bone marrow dosimetry for 141Ce-EDTMP as a potential bone pain palliation complex: a Monte Carlo study","volume":"182","author":"Dalvand","year":"2022","journal-title":"Appl. Radiat. Isot."},{"issue":"4 SI","key":"10.1016\/j.apradiso.2024.111300_bib8","first-page":"1683","article-title":"Comparison of clinical effect in treatment of bone tumor between zoledronic acid needle and ibandronate needle","volume":"31","author":"Han","year":"2018","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.apradiso.2024.111300_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2023.110788","article-title":"Internal dosimetry of 64Cu-DOX-loaded microcapsules by Monte Carlo method","volume":"196","author":"Heidari","year":"2023","journal-title":"Appl. Radiat. Isot."},{"issue":"7","key":"10.1016\/j.apradiso.2024.111300_bib10","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s00259-022-05697-w","article-title":"Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival","volume":"49","author":"Jannin","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"8","key":"10.1016\/j.apradiso.2024.111300_bib11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/RLU.0000000000004717","article-title":"177Lu-DOTA-IBA therapy in prostate cancer with bone metastases","volume":"48","author":"Li","year":"2023","journal-title":"Clin. Nucl. Med."},{"issue":"6","key":"10.1016\/j.apradiso.2024.111300_bib12","first-page":"953","article-title":"Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases","volume":"44","author":"Liepe","year":"2003","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2024.111300_bib13","article-title":"Rhenium-186-HEDP dosimetry and multiple bone metastases palliation therapy effects","author":"Lyra","year":"2003","journal-title":"Radionuclide Therapy for Oncology Current Status and Future Aspects"},{"issue":"19","key":"10.1016\/j.apradiso.2024.111300_bib14","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rpd\/ncac190","article-title":"Development and estimation of human dosimetry of a new 47Sc-risedronate for radiopharmaceutical application","volume":"198","author":"Moghaddam-Banaem","year":"2022","journal-title":"Radiat. Protect. Dosim."},{"issue":"2","key":"10.1016\/j.apradiso.2024.111300_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.net.2022.10.022","article-title":"Prediction of radiation dose to adult human from radiopharmaceutical manufactured by third generation bisphosphonate labeled with Rhenium","volume":"55","author":"Pourhabib","year":"2023","journal-title":"Nucl. Eng. Technol."},{"key":"10.1016\/j.apradiso.2024.111300_bib16","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s10967-019-06816-y","article-title":"Appraisement of 186\/188 Re-HEDP, a new compositional radiopharmaceutical","volume":"322","author":"Pourhabib","year":"2019","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"10.1016\/j.apradiso.2024.111300_bib17","first-page":"10","article-title":"Safety and efficacy of 68Ga-or 177Lu-labeled DOTA-IBA as a novel theranostic radiopharmaceutical for bone metastases: a phase 0\/I study","author":"Qiu","year":"2022","journal-title":"Clin. Nucl. Med."},{"issue":"1","key":"10.1016\/j.apradiso.2024.111300_bib18","first-page":"11","article-title":"Development of 153Sm\/177Lu-EDTMP as a possible therapeutic complex","volume":"25","author":"Ranjbar","year":"2017","journal-title":"Iran. J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.apradiso.2024.111300_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1055\/a-1486-3683","article-title":"Human absorbed dose evaluation of [177Lu] Lu-IBA as a bone palliative candidate","volume":"60","author":"Ranjbar","year":"2021","journal-title":"Nuklearmedizin-NuclearMedicine"},{"key":"10.1016\/j.apradiso.2024.111300_bib20","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/BF01084371","article-title":"Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography","volume":"23","author":"R\u00f6sch","year":"1996","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2024.111300_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2022.110273","article-title":"Internal dosimetry studies of 177Lu-BBN-GABA-DOTA, as a cancer therapy agent, in human tissues based on animal data","volume":"186","author":"Sahafi-Pour","year":"2022","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.apradiso.2024.111300_bib22","first-page":"1","article-title":"Imaging and dosimetry for alpha-particle emitter radiopharmaceutical therapy: improving radiopharmaceutical therapy by looking into the black box","author":"Sgouros","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.apradiso.2024.111300_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fmed.2017.00046","article-title":"Comparative therapeutic efficacy of 153Sm-EDTMP and 177Lu-EDTMP for bone pain palliation in patients with skeletal metastases: patients' pain score analysis and personalized dosimetry","volume":"4","author":"Sharma","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.apradiso.2024.111300_bib24","series-title":"Comparison Of the Effectiveness of Some Common Animal Data Scaling Techniques in Estimating Human Radiation Dose (No. ORISE-99-0164-Vol. 2; CONF-960536-PROC.-Vol. 2)","author":"Sparks","year":"1999"},{"issue":"6","key":"10.1016\/j.apradiso.2024.111300_bib25","first-page":"1023","article-title":"OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine","volume":"46","author":"Stabin","year":"2005","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.apradiso.2024.111300_bib26","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1021\/acs.molpharmaceut.2c00978","article-title":"Lutetium177-Labeled DOTA-Ibandronate: a novel radiopharmaceutical for targeted treatment of bone metastases","volume":"20","author":"Wang","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.apradiso.2024.111300_bib27","article-title":"Preparation, characterization, and preliminary imaging study of [188 Re] Re-ibandronate as a novel theranostic radiopharmaceutical for bone metastasis","volume":"2022","author":"Xu","year":"2022","journal-title":"Contrast Media Mol. Imaging"},{"issue":"1","key":"10.1016\/j.apradiso.2024.111300_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jlcr.3694","article-title":"Radiolabeling, quality control, biodistribution, and imaging studies of 177Lu\u2010ibandronate","volume":"62","author":"Xu","year":"2019","journal-title":"J. Label. Compd. Radiopharm."},{"issue":"4","key":"10.1016\/j.apradiso.2024.111300_bib29","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.net.2022.12.037","article-title":"Radiation dosimetry of 89Zr labeled antibody estimated using the MIRD method and MCNP code","volume":"55","author":"Yazdi","year":"2023","journal-title":"Nucl. Eng. Technol."}],"container-title":["Applied Radiation and Isotopes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804324001283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804324001283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T14:49:22Z","timestamp":1712846962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969804324001283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":28,"alternative-id":["S0969804324001283"],"URL":"https:\/\/doi.org\/10.1016\/j.apradiso.2024.111300","relation":{},"ISSN":["0969-8043"],"issn-type":[{"value":"0969-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of 188Re- IBA as a novel radiopharmaceutical for bone marrow ablation","name":"articletitle","label":"Article Title"},{"value":"Applied Radiation and Isotopes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apradiso.2024.111300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111300"}}